Consolidated Statements Of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 27, 2015	Sep. 28, 2014
Cash flows from operating activities:
Net (loss) earnings	$ (16,042)	$ 5,650
Adjustments to reconcile net (loss) earnings to net cash provided by operating activities:
Depreciation and amortization	19,188	18,712
Amortization of debt issuance costs	325	325
Interest on financing liability	1,479	1,686
Deferred taxes	(1,030)	11,329
Stock-based compensation	4,116	4,349
Provision for losses on accounts receivable	(152)	75
Excess tax benefit on stock-based compensation	(104)	(6)
(Gain) loss on disposal of fixed assets	(214)	105
Litigation matters	6,584	0
Restructuring related asset impairment	0	172
Decrease (increase) in operating assets:
Accounts receivable	12,801	34,653
Inventories	(8,275)	(19,797)
Other assets	7,316	4,678
(Decrease) increase in operating liabilities:
Accounts payable	(5,890)	(8,844)
Income taxes	(566)	(987)
Unearned revenues - current	890	(131)
Restructuring reserve	(3,888)	(3,658)
Other liabilities	(8,830)	(6,417)
Net cash provided by operating activities	7,708	41,894
Cash flows from investing activities:
Acquisition of property, plant, and equipment and intangibles	(13,922)	(12,833)
Cash receipts on note receivable from sale of discontinued operations	212	212
Other investing activities	290	77
Net cash used in investing activities	(13,420)	(12,544)
Cash flows from financing activities:
Proceeds from stock issuances	1,131	1,378
Excess tax benefit on stock-based compensation	104	6
Net change in factoring and bank overdrafts	24	(110)
Proceeds from long-term debt	0	1,000
Payment of long-term debt	(71)	(7,217)
Purchase of treasury stock	(3,146)	0
Dividend paid	(20,980)	0
Net cash used in financing activities	(22,938)	(4,943)
Effect of foreign currency rate fluctuations on cash and cash equivalents	(8,837)	(4,471)
Net (decrease) increase in cash and cash equivalents	(37,487)	19,936
Cash and cash equivalents:
Beginning of period	135,537	121,573
End of period	$ 98,050	$ 141,509